2017 Jan 25
We Are Weill Cornell Medicine: Dr. Heather Yeo
Heather Yeo, M.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2017 Jan 25
A prostate cancer that sidesteps therapy
Feature about the work of Himisha Beltran, M.D., to uncover the evolution of aggressive forms of prostate cancer. Read more
2017 Jan 18
Cantley named as NCI Outstanding Investigator
Meyer director Lewis Cantley will receive $4.2 million over 7 years to continue his research into PI3K and cancer metabolism. Read more
2017 Jan 17
Ofatumumab improves overall response in Waldenström macroglobulinemia
A study by Richard Furman, M.D., found that ofatumumab may be a non-chemotherapeutic option for patients with Waldenström macroglobulinemia. Read more
2017 Jan 17
My visit to the medical Holodeck
Feature about the use of virtual reality for cancer research at Weill Cornell Medicine. Read more
2017 Jan 13
Anti-science culture is growing, say Nobel Laureates
Harold Varmus, M.D., warned against the "anti-science movement" during a visit to India for the Nobel Prize Series. Read more
2017 Jan 12
Exploring epigenetic therapy for aggressive prostate cancer
With the help of a 2016 Lori Milken–PCF Young Investigator Award from the Prostate Cancer Foundation, Loredana Puca, Ph.D., is studying the genomic characteristics of neuroendocrine prostate cancer and whether it might be possible to develop an epigenetic therapy to treat it. Read more
2017 Jan 11
Weill/NYP support updated HPV vaccine recommendations
NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine are among the nation’s top healthcare institutions in supporting revised vaccination guidelines from the Centers for Disease Control and Prevention (CDC) for the human papillomavirus (HPV). Read more
2017 Jan 09
'Radical collaboration' sets its sights on cancer treatment
Lewis C. Cantley, Ph.D., and Kristy Richards, Ph.D., M.D. are collaborating to revamp the ways cancer drugs can be researched, tested and approved. Read more
2017 Jan 05
Tailored organoid may help unravel immune response mystery
An Ithaca-NYC team has developed a modular immune organoid that can replicate the anatomical structures found within lymph nodes to mimic the early stages of a germinal center, where B cell differentiation and initiation of immunological responses take place during infection. Read more
2017 Jan 05
When should you be screened? Important cancer tests you shouldn't miss
Felice Schnoll-Sussman, M.D., appeared on the TODAY Show to review cancer screening guidelines by age Read more
2017 Jan 04
Copper toned research trial offers new hope in finding a cure for cancer
TV coverage of Linda Vahdat's copper depletion trial, and the crowdfunding initiative she has started to fund it. Read more
2017 Jan 04
Softening of tumor tissue could aid in cancer drug delivery
An Ithaca-NYC team has found that the stiffening of the matrix surrounding a metastatic tumor plays a key role in the vascular makeup of the tumor that promotes tumor growth and mobility by keeping drugs out. Read more
2016 Dec 29
Incidence of metastatic prostate cancer in older men increases following drop in PSA screening
The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011, according to new research from Jim Hu, M.D. Read more
2016 Dec 28
Breast center launches innovative crowdfunding campaign to fund clinical trial
Linda Vahdat, M.D., is turning to the public to help fund a trial for a new triple negative breast cancer treatment involving a simple oral medication that reduces copper levels in the patient’s body Read more
2016 Dec 24
The profound impacts of patients
Jeffrey Greenfield, M.D., Ph.D., shared his story about how one patient had a profound impact on his career. Read more
2016 Dec 22
7 Warning Signs Of A Brain Tumor You Should Know
Neurosurgeon Theodore Schwartz, M.D., shares some brain tumor symptoms. Read more
2016 Dec 21
Metabolic pathways may provide opportunity for novel therapeutic targeting in neuro-oncology
Howard Fine, M.D., discusses the investigation of metabolic pathways in brain tumors to identify potential new therapeutic targets. Read more
2016 Dec 21
Research reveals codes that control protein expression
An internal code in messenger RNA predetermines how much protein they will produce, according to a new study by Samie Jaffrey. Read more
2016 Dec 20
End-of-life discussions held at ‘astounding’ infrequency
Ninety-five percent of patients with advanced cancer have an insufficient understanding of their prognosis and are ill-equipped to make informed end-of-life care decisions, according to a study by Holly Prigerson, Ph.D., and colleagues. Read more
